BIO CEO & Investor Conference Company Presentations FAQ

  • Recommend
  • Tweet
  • Print
  • Email

Q: What is a Company Presentation?

A: Company Presentations at the BIO CEO & Investor Conference are corporate pitch slide presentations given by senior-level executives. They showcase a company's pipeline, R&D activities, business objectives and investment goals. They range from 13 minutes to 25 minutes, depending on the ownership of the company presenting.

Q: Why do companies present?

A: Companies and organizations present at the BIO CEO & Investor Conference to get in front of an exclusive audience of public and private equity investors, plus other biotech executives. Presenters also receive exclusive benefits not available to general attendees, including pre-conference marketing (such as email newsletters, press releases, etc.), designation in the One-on-One Partnering™ System, and the opportunity to participate in exclusive content on the BIOtechNow blog. Companies interested in webcasting will also have the option to purchase a package for an additional fee, which will be available to view on BIO's CEO & Investor Conference website and widens a presentation's reach.

Q: Who can present?

A: The BIO CEO & Investor Conference will feature presentations primarily by public companies, as well as a track of established private companies (Series B companies that have raised >$25M to date). Those interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, or platform technologies. This can include patient advocacy groups. Service providers will not be considered, but should email George at if interested in sponsorship opportunities.

Q: How can we get a presentation spot at this event?

A: All companies and organizations who are interested in presenting are encouraged to submit an application. Your application will be reviewed, and you will be notified shortly on its status. Should your application be accepted, registration and logistical details will be provided.

Q: What is the deadline to submit an application?

A: Applications should be submitted by the beginning of December. This will provide enough time to review the application before the Early Bird Registration Rates expire on December 17, 2015. However, companies are encouraged to submit applications at any time. Once presentation spots are sold out, applications will be wait listed, and companies will be notified if/when a presentation slot becomes available.

Q: What registration do I need to present?

A: Presenters must purchase a registration pass in order to obtain access to the sessions, One-on-One Partnering™ System, lunches, and networking events. Click here for more information on each type of company presentation and its cost structure. In general, the more people from a company who attend the event, the greater the discount on the registration fees.

Q: Are there any additional fees associated with presenting?

A: Yes. Presentation fees differ depending on company type. Please refer to the link above for more information. Presentation fees are not included in group package rates.

Q: How long are the presentations?

A: Public company presentations are 25 minutes in length. Private companies are 13 minutes in length, and are noted as such in the conference program and materials. All Q&A from the audience, should a company want to take questions, are included in those times.

Q: Are there breakout sessions after presentations?

A: No, presenters do not have follow-up sessions after a presentation has concluded. Instead, we advise that interested parties visit the onsite One-on-One Partnering™ desk to schedule a private meeting, or utilize the common areas in the Waldorf.

Q: Are there options to help smaller companies get a chance to present?

A: The BIO CEO & Investor Conference is targeted toward public companies. However, a limited number of established private companies are encouraged to present. Established private companies are defined as having passed their Series B financing round and having raised >$25M. For emerging private companies, who have raised <$25M, we recommend considering a presentation at the BIO Investor Forum. This conference features a special pricing structure for "Discovery Companies," which is specifically focused on companies in Seed- or Series-A financing rounds that have raised less than $25M. The BIO Investor Forum is focused on venture-stage growth and emerging public companies. More information about presenting at the BIO Investor Forum can be found here.

Q: Who can attend the presentations?

A: All registered attendees and investors have full access to the company presentations at this event. For companies that purchase webcasting, links will be made available on the BIO CEO & Investor Conference site. Please note, there are no day passes or special exceptions made for individuals or companies looking to attend a particular company's presentation.

Q: How do I purchase webcasting?

A: The webcast order form will be made available at a later date.

Q: Who can I contact for more information?

A: Please email us at